| EXAGEN INC. DL-,001 |
| USA |
| Gesundheit |
| US30068X1037 / A2PRXT |
| E08A (Frankfurt) / XGN (NASDAQ) |
| FRA:E08A, ETR:E08A, E08A:GR, NASDAQ:XGN |
| - |
| https://exagen.com/ |
|
Exagen Inc. is a biotechnology company that focuse..
>Volltext.. |
| 226.54 Mio. EUR |
| 222.43 Mio. EUR |
| 51.23 Mio. EUR |
| -10.7 Mio. EUR |
| -14.78 Mio. EUR |
| -0.78 EUR |
| 21.93 Mio. EUR |
| 26.14 Mio. EUR |
| -13.38 Mio. EUR |
| 2.92 |
| -5.54% |
| 10.83% |
| - |
| - |
| - |
| EXAGEN |
| 04.11.25 |
|